A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the effectiveness of 2 target doses of
R228060 in comparison with placebo during 6 weeks of treatment in moderately to severely
depressed adult subjects with major depressive disorder.
Approximately 488 subjects will be involved in the study.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.